The putative somatostatin antagonist cyclo-somatostatin has opioid agonist effects in gastrointestinal preparations

R. Benkó, Angelina Antwi, L. Barthó

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aims: Specificity of receptor antagonists used is crucial for clarifying physiological/pathophysiological roles of the respective endogenous agonist. We studied the effects (somatostatin antagonist and possibly other actions) of cyclo-somatostatin (CSST), a putative somatostatin receptor antagonist on the guinea-pig small intestine, a preparation where somatostatin causes inhibition of nerve-mediated contractions. Main methods: In isolated organ experiments, half-maximal cholinergic "twitch" contractions of the guinea-pig small intestine were evoked or tonic contractions of the rat stomach fundus strip (in the presence of physostigmine) were elicited by electrical field stimulation. The effects of somatostatin (somatostatin-14), CSST, naloxone, as well as of direct smooth muscle stimulants were examined. Key findings: Somatostatin (10 nM-1 μM) caused transient inhibition of the twitch contraction, in a naloxone-insensitive manner. Surprisingly, CSST (0.3-1 μM) also inhibited twitch contractions (more than 50% reduction at 1 μM). This effect was prevented by the opioid receptor antagonist naloxone. Responses to acetylcholine or histamine were not or only minimally inhibited by CSST (up to 3 μM). CSST (0.3 μM in the absence or 1-10 μM in the presence of naloxone) failed to inhibit the effect of somatostatin. The SST 2 receptor antagonist CYN-154806 (3 μM) attenuated the effect of somatostatin and failed to evoke naloxone-sensitive inhibition of the twitch response. The naloxone-sensitive inhibitory effect of CSST on cholinergic contractions was also confirmed in the rat stomach fundus preparation. Significance: Cyclo-somatostatin exerts opioid agonist activity in the two preparations tested, while it does not behave as a somatostatin-receptor antagonist in the guinea-pig intestine.

Original languageEnglish
Pages (from-to)728-732
Number of pages5
JournalLife Sciences
Volume90
Issue number19-20
DOIs
Publication statusPublished - May 22 2012

Fingerprint

Somatostatin
Opioid Analgesics
Naloxone
Somatostatin Receptors
Guinea Pigs
Cholinergic Agents
Small Intestine
Rats
Stomach
Physostigmine
Narcotic Antagonists
Histamine
Electric Stimulation
Acetylcholine
Intestines
Smooth Muscle
Muscle

Keywords

  • Cholinergic contractions
  • Cyclo-somatostatin
  • CYN-154806
  • Guinea-pig ileum
  • Naloxone
  • Opioid agonist
  • Rat stomach fundus strip
  • Somatostatin

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The putative somatostatin antagonist cyclo-somatostatin has opioid agonist effects in gastrointestinal preparations. / Benkó, R.; Antwi, Angelina; Barthó, L.

In: Life Sciences, Vol. 90, No. 19-20, 22.05.2012, p. 728-732.

Research output: Contribution to journalArticle

@article{d4327fb8e84e4e17b37ee0393f91da58,
title = "The putative somatostatin antagonist cyclo-somatostatin has opioid agonist effects in gastrointestinal preparations",
abstract = "Aims: Specificity of receptor antagonists used is crucial for clarifying physiological/pathophysiological roles of the respective endogenous agonist. We studied the effects (somatostatin antagonist and possibly other actions) of cyclo-somatostatin (CSST), a putative somatostatin receptor antagonist on the guinea-pig small intestine, a preparation where somatostatin causes inhibition of nerve-mediated contractions. Main methods: In isolated organ experiments, half-maximal cholinergic {"}twitch{"} contractions of the guinea-pig small intestine were evoked or tonic contractions of the rat stomach fundus strip (in the presence of physostigmine) were elicited by electrical field stimulation. The effects of somatostatin (somatostatin-14), CSST, naloxone, as well as of direct smooth muscle stimulants were examined. Key findings: Somatostatin (10 nM-1 μM) caused transient inhibition of the twitch contraction, in a naloxone-insensitive manner. Surprisingly, CSST (0.3-1 μM) also inhibited twitch contractions (more than 50{\%} reduction at 1 μM). This effect was prevented by the opioid receptor antagonist naloxone. Responses to acetylcholine or histamine were not or only minimally inhibited by CSST (up to 3 μM). CSST (0.3 μM in the absence or 1-10 μM in the presence of naloxone) failed to inhibit the effect of somatostatin. The SST 2 receptor antagonist CYN-154806 (3 μM) attenuated the effect of somatostatin and failed to evoke naloxone-sensitive inhibition of the twitch response. The naloxone-sensitive inhibitory effect of CSST on cholinergic contractions was also confirmed in the rat stomach fundus preparation. Significance: Cyclo-somatostatin exerts opioid agonist activity in the two preparations tested, while it does not behave as a somatostatin-receptor antagonist in the guinea-pig intestine.",
keywords = "Cholinergic contractions, Cyclo-somatostatin, CYN-154806, Guinea-pig ileum, Naloxone, Opioid agonist, Rat stomach fundus strip, Somatostatin",
author = "R. Benk{\'o} and Angelina Antwi and L. Barth{\'o}",
year = "2012",
month = "5",
day = "22",
doi = "10.1016/j.lfs.2012.03.007",
language = "English",
volume = "90",
pages = "728--732",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "19-20",

}

TY - JOUR

T1 - The putative somatostatin antagonist cyclo-somatostatin has opioid agonist effects in gastrointestinal preparations

AU - Benkó, R.

AU - Antwi, Angelina

AU - Barthó, L.

PY - 2012/5/22

Y1 - 2012/5/22

N2 - Aims: Specificity of receptor antagonists used is crucial for clarifying physiological/pathophysiological roles of the respective endogenous agonist. We studied the effects (somatostatin antagonist and possibly other actions) of cyclo-somatostatin (CSST), a putative somatostatin receptor antagonist on the guinea-pig small intestine, a preparation where somatostatin causes inhibition of nerve-mediated contractions. Main methods: In isolated organ experiments, half-maximal cholinergic "twitch" contractions of the guinea-pig small intestine were evoked or tonic contractions of the rat stomach fundus strip (in the presence of physostigmine) were elicited by electrical field stimulation. The effects of somatostatin (somatostatin-14), CSST, naloxone, as well as of direct smooth muscle stimulants were examined. Key findings: Somatostatin (10 nM-1 μM) caused transient inhibition of the twitch contraction, in a naloxone-insensitive manner. Surprisingly, CSST (0.3-1 μM) also inhibited twitch contractions (more than 50% reduction at 1 μM). This effect was prevented by the opioid receptor antagonist naloxone. Responses to acetylcholine or histamine were not or only minimally inhibited by CSST (up to 3 μM). CSST (0.3 μM in the absence or 1-10 μM in the presence of naloxone) failed to inhibit the effect of somatostatin. The SST 2 receptor antagonist CYN-154806 (3 μM) attenuated the effect of somatostatin and failed to evoke naloxone-sensitive inhibition of the twitch response. The naloxone-sensitive inhibitory effect of CSST on cholinergic contractions was also confirmed in the rat stomach fundus preparation. Significance: Cyclo-somatostatin exerts opioid agonist activity in the two preparations tested, while it does not behave as a somatostatin-receptor antagonist in the guinea-pig intestine.

AB - Aims: Specificity of receptor antagonists used is crucial for clarifying physiological/pathophysiological roles of the respective endogenous agonist. We studied the effects (somatostatin antagonist and possibly other actions) of cyclo-somatostatin (CSST), a putative somatostatin receptor antagonist on the guinea-pig small intestine, a preparation where somatostatin causes inhibition of nerve-mediated contractions. Main methods: In isolated organ experiments, half-maximal cholinergic "twitch" contractions of the guinea-pig small intestine were evoked or tonic contractions of the rat stomach fundus strip (in the presence of physostigmine) were elicited by electrical field stimulation. The effects of somatostatin (somatostatin-14), CSST, naloxone, as well as of direct smooth muscle stimulants were examined. Key findings: Somatostatin (10 nM-1 μM) caused transient inhibition of the twitch contraction, in a naloxone-insensitive manner. Surprisingly, CSST (0.3-1 μM) also inhibited twitch contractions (more than 50% reduction at 1 μM). This effect was prevented by the opioid receptor antagonist naloxone. Responses to acetylcholine or histamine were not or only minimally inhibited by CSST (up to 3 μM). CSST (0.3 μM in the absence or 1-10 μM in the presence of naloxone) failed to inhibit the effect of somatostatin. The SST 2 receptor antagonist CYN-154806 (3 μM) attenuated the effect of somatostatin and failed to evoke naloxone-sensitive inhibition of the twitch response. The naloxone-sensitive inhibitory effect of CSST on cholinergic contractions was also confirmed in the rat stomach fundus preparation. Significance: Cyclo-somatostatin exerts opioid agonist activity in the two preparations tested, while it does not behave as a somatostatin-receptor antagonist in the guinea-pig intestine.

KW - Cholinergic contractions

KW - Cyclo-somatostatin

KW - CYN-154806

KW - Guinea-pig ileum

KW - Naloxone

KW - Opioid agonist

KW - Rat stomach fundus strip

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=84860711372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860711372&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2012.03.007

DO - 10.1016/j.lfs.2012.03.007

M3 - Article

VL - 90

SP - 728

EP - 732

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 19-20

ER -